Kura Oncology, Inc.KURANASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+38.3%
5Y CAGR+13.0%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
+38.3%/yr
vs -10.4%/yr prior
5Y CAGR
+13.0%/yr
Recent acceleration
Acceleration
+48.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.23 | +188.3% |
| 2024 | 1.81 | -31.6% |
| 2023 | 2.65 | +34.0% |
| 2022 | 1.98 | +7.9% |
| 2021 | 1.83 | -35.4% |
| 2020 | 2.84 | +7.6% |
| 2019 | 2.64 | -14.1% |
| 2018 | 3.07 | -31.1% |
| 2017 | 4.45 | +129.5% |
| 2016 | 1.94 | - |